We are a global team dedicated to improve the lives of patients with Fragile X Syndrome and Autism Spectrum Disorder. Our work spans three decades of research in neuroscience and intellectual disabilities. The “mGluR theory of fragile X” proposed by MIT Professor Mark Bear and collaborators in 2004 ...
Use this information to figure out if this company is an ideal customer for you.
Honolulu
Allos Pharma's CEO is Randall Carpenter
Allos Pharma's HQ is located at Honolulu
Allos Pharma's official website is allospharma.com
Allos Pharma's revenue is $1M - $5M
Allos Pharma has 11 - 50 employees
Allos Pharma is in the industry of: Pharmaceuticals